or Try an Advanced Search...

    Specialty Drugs Stocks List

    Symbol Grade Name % Change
    RZLT A Rezolute, Inc. 3.21
    DCTH A Delcath Systems, Inc. 13.14
    PRTC B PureTech Health plc 0.00
    BHC D Bausch Health Companies Inc. -2.76
    CVS D CVS Caremark Corporation -0.17
    OTLK D Outlook Therapeutics, Inc. -0.98
    OPCH D Option Care Health, Inc. -2.16
    INZY F Inozyme Pharma, Inc. -2.66
    ORIC F Oric Pharmaceuticals, Inc. -5.11
    TAK F Takeda Pharmaceutical Company Limited 0.91
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Care Plans Medical Care Medical Devices
    Related Stock Lists: Biotechnology Biopharmaceutical Life Sciences Pharmacy Disease Immunology Medicine Monoclonal Antibody Alzheimer's Disease Biology Cancer Cancer Treatment Gastrointestinal Lymphedema Monoclonal Antibodies Psoriasis S&P 500 Treatment Of Cancer Acne Actinic Keratosis

    Related ETFs - A few ETFs which own one or more of the above listed Specialty Drugs stocks.

    Symbol Grade Name Weight
    BIS A ProShares UltraShort Nasdaq Biotechnology 6.12
    IHF B iShares U.S. Health Care Providers ETF 5.27
    PBE D PowerShares Dynamic Biotech & Genome 4.73
    CFCV A ClearBridge Focus Value ETF 4.54
    DIP B BTD Capital Fund 4.41
    View all Specialty Drugs ETFs...
    Compare ETFs
    Compare BIS to CFCV Compare BIS to PBE Compare IHF to DIP

        Specialty Drugs Stocks Recent News

        Date Stock Title
        Apr 22 OPCH Option Care Health Q1 2024 Earnings Preview
        Apr 22 CVS CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
        Apr 22 OPCH Will Option Care (OPCH) Beat Estimates Again in Its Next Earnings Report?
        Apr 22 OPCH Should You Investigate Option Care Health, Inc. (NASDAQ:OPCH) At US$31.08?
        Apr 22 CVS Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It?
        Apr 22 TAK Pharmas form joint venture to jumpstart Japanese drug research
        Apr 22 TAK Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
        Apr 20 CVS CVS treatment program discriminates against people with HIV, judge says
        Apr 20 BHC 10 Best Healthcare Stocks to Buy Under $20
        Apr 19 CVS CVS Health (CVS) Ascends While Market Falls: Some Facts to Note
        Apr 19 TAK MasterCraft Boat, SentinelOne, and More Stocks See Action From Activist Investors
        Apr 19 CVS Alvotech deal could heighten biosimilar pressure on Humira
        Apr 18 TAK U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
        Apr 18 CVS CVS Health (CVS) Rises As Market Takes a Dip: Key Facts
        Apr 18 CVS Elevance Health Offers More Relief on Medical Costs for Worried Investors
        Apr 18 CVS CVS Health (CVS) to Report Q1 Earnings: What's in the Cards?
        Apr 18 CVS CVS Health Corp's Dividend Analysis
        Apr 18 PRTC PureTech Health: Notice of Results
        Apr 17 CVS CVS favors Humira copycats hurting AbbVie’s market share: Evercore
        Apr 17 CVS Freeport-McMoRan, AppLovin And A Major Healthcare Stock On CNBC's 'Final Trades'
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Care Plans Medical Care Medical Devices
        Related Stock Lists: Biotechnology Biopharmaceutical Life Sciences Medicine Pharmacy Autoimmune Disorders Cancer Chemotherapy Clinical Medicine Colitis Diarrhea Disease Immune Disorders Oncology Psoriasis S&P 500 Ulcerative Colitis Abdominal Pain Acne Actinic Keratosis
        Specialty Drugs

        Specialty drugs are medications that are used to treat complex and chronic conditions, such as cancer, multiple sclerosis, and rheumatoid arthritis. They are typically more expensive than traditional medications and require special handling, storage, and administration. Specialty drugs may also require special monitoring and close follow-up with a healthcare provider.

        Browse All Tags